 |
|
2022 Consensus statement on the management of familial hypercholesterolemia in Korea
Chan Joo Lee, Minjae Yoon, Hyun-Jae Kang, Byung Jin Kim, Sung Hee Choi, In-Kyung Jeong, Sang-Hak Lee, ,
Korean J Intern Med. 2022;37(5):931-944. Published online 2022 Jul 27 DOI: https://doi.org/10.3904/kjim.2022.121
|
|
Citations to this article as recorded by
 A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia
Rui Meng, Qiran Wei, Jiting Zhou, Baoming Zhang, Chao Li, Mingwang Shen
Journal of Clinical Lipidology.2024; 18(1): e21. CrossRef Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia
Richard Malone, Sarah Savage, Vivion Crowley, Martina Hennessy, Patricia O’Connor, Cormac Kennedy
Journal of Clinical Medicine.2024; 13(8): 2270. CrossRef Familial Hypercholesterolemia in Children. The Current State of the Problem
Dinara I. Sadykova, Karina R. Salakhova, Liliya F. Galimova, Eugeniya S. Slastnikova, Chulpan D. Khaliullina
Current Pediatrics.2023; 22(3): 231. CrossRef Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis.2023; 30(11): 1525. CrossRef Sitosterolemia caused by mutations in the ABCG8 gene. First case report in Colombia
Harold Felipe Saavedra-López, Sandra Yaneth Ospina-Lagos, Maria Paula Blanco-Bustos
Revista de la Facultad de Medicina.2023; 71(4): e107181. CrossRef
|